At a strategic level, direct CAFs depletion can rapidly disrupt stromal barriers to drug delivery, but it risks eliminating tumor-restraining CAFs subpopulations and triggering adverse stromal reactions, emphasizing the need for higher selectivity 39. This evidence concerns the gene TBX1 and neoplasm.